Intravenöse Lyse-Therapie beim ischämischen Schlaganfall – Schritt für Schritt

Article Properties
Cite
Schell, Maximilian, and Götz Thomalla. “Intravenöse Lyse-Therapie Beim ischämischen Schlaganfall – Schritt für Schritt”. Neurologie up2date, vol. 03, no. 04, 2020, pp. 329-36, https://doi.org/10.1055/a-1163-4712.
Schell, M., & Thomalla, G. (2020). Intravenöse Lyse-Therapie beim ischämischen Schlaganfall – Schritt für Schritt. Neurologie up2date, 03(04), 329-336. https://doi.org/10.1055/a-1163-4712
Schell, Maximilian, and Götz Thomalla. “Intravenöse Lyse-Therapie Beim ischämischen Schlaganfall – Schritt für Schritt”. Neurologie up2date 03, no. 04 (2020): 329-36. https://doi.org/10.1055/a-1163-4712.
Schell M, Thomalla G. Intravenöse Lyse-Therapie beim ischämischen Schlaganfall – Schritt für Schritt. Neurologie up2date. 2020;03(04):329-36.
Refrences
Title Journal Journal Categories Citations Publication Date
Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke New England Journal of Medicine
  • Medicine: Medicine (General)
  • Medicine: Internal medicine
  • Medicine: Medicine (General)
  • Medicine: Medicine (General)
 2019
MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset New England Journal of Medicine
  • Medicine: Medicine (General)
  • Medicine: Internal medicine
  • Medicine: Medicine (General)
  • Medicine: Medicine (General)
 2018
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials 2014
A randomized trial of tenecteplase versus alteplase for acute ischemic stroke New England Journal of Medicine
  • Medicine: Medicine (General)
  • Medicine: Internal medicine
  • Medicine: Medicine (General)
  • Medicine: Medicine (General)
 2012
Risks of Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Receiving Warfarin and Treated With Intravenous Tissue Plasminogen Activator JAMA
  • Medicine: Medicine (General)
  • Medicine: Internal medicine
  • Medicine: Medicine (General)
  • Medicine: Medicine (General)
 121 2012
Refrences Analysis
Category Category Repetition
Medicine: Medicine (General)12
Medicine: Internal medicine4
The category Medicine: Medicine (General) 12 is the most frequently represented among the references in this article. It primarily includes studies from New England Journal of Medicine The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
Title Journal Journal Categories Citations Publication Date
Risk Profiles of New Users of Oral Anticoagulants Between 2011 and 2019 in Germany Clinical Epidemiology
  • Medicine: Internal medicine: Infectious and parasitic diseases
  • Medicine: Internal medicine: Special situations and conditions: Industrial medicine. Industrial hygiene
  • Medicine: Public aspects of medicine
  • Medicine: Medicine (General)
 2023
Citations Analysis
Category Category Repetition
Medicine: Internal medicine: Infectious and parasitic diseases1
Medicine: Internal medicine: Special situations and conditions: Industrial medicine. Industrial hygiene1
Medicine: Public aspects of medicine1
Medicine: Medicine (General)1
The category Medicine: Internal medicine: Infectious and parasitic diseases 1 is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Risk Profiles of New Users of Oral Anticoagulants Between 2011 and 2019 in Germany and was published in 2023. The most recent citation comes from a 2023 study titled Risk Profiles of New Users of Oral Anticoagulants Between 2011 and 2019 in Germany. This article reached its peak citation in 2023, with 1 citations. It has been cited in 1 different journals, 100% of which are open access. Among related journals, the Clinical Epidemiology cited this research the most, with 1 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year